NKI-AVL
NKI-AVL
Amsterdam, North Holland, Netherlands3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 2 | 2026-07-15 | NCT06237920 | |
| Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm, squamous cell carcinoma of penis, urinary system disorder | Recruiting | Phase 2 | 2025-12-08 | NCT06353906 | |
| The Radium-select Study | Male Urogenital Diseases, Urogenital Diseases | Recruiting | Not applicable | 2025-07-08 | NCT06659926 |